BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 21597229)

  • 1. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH.
    Igaki JM; Yamada M; Yamazaki Y; Koto S; Izawa M; Ariyasu D; Suzuki E; Hasegawa H; Hasegawa Y
    Endocr J; 2011; 58(8):647-55. PubMed ID: 21597229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study).
    Smith PS; Gottesman GS; Zhang F; Cook F; Ramirez B; Wenkert D; Wollberg V; Huskey M; Mumm S; Whyte MP
    J Bone Miner Res; 2020 May; 35(5):920-931. PubMed ID: 31910300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia.
    Zhang C; Zhao Z; Sun Y; Xu L; JiaJue R; Cui L; Pang Q; Jiang Y; Li M; Wang O; He X; He S; Nie M; Xing X; Meng X; Zhou X; Yan L; Kaplan JM; Insogna KL; Xia W
    Bone; 2019 Apr; 121():212-220. PubMed ID: 30682568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
    Ichikawa S; Austin AM; Gray AK; Econs MJ
    J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approach of renal hypophosphatemia.
    Giralt M; Chocron S; Ferrer R; Ariceta G
    Pediatr Nephrol; 2021 Apr; 36(4):1025-1028. PubMed ID: 33492457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets.
    Li SS; Gu JM; Yu WJ; He JW; Fu WZ; Zhang ZL
    Int J Mol Med; 2016 Dec; 38(6):1703-1714. PubMed ID: 27840894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
    Kinoshita Y; Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujita T
    Eur J Endocrinol; 2012 Aug; 167(2):165-72. PubMed ID: 22577109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic Disorders.
    Ramos P; Larson B; Ashrafzadeh-Kian S; Ito N; Kato H; Bornhorst JA; Algeciras-Schimnich A
    Endocr Pract; 2023 Mar; 29(3):193-198. PubMed ID: 36627024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients.
    Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY
    In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.
    Rush ET; Johnson B; Aradhya S; Beltran D; Bristow SL; Eisenbeis S; Guerra NE; Krolczyk S; Miller N; Morales A; Ramesan P; Sarafrazi S; Truty R; Dahir K
    J Bone Miner Res; 2022 Feb; 37(2):202-214. PubMed ID: 34633109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23 and its role in X-linked hypophosphatemia-related morbidity.
    Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O
    Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.
    Xia W; Meng X; Jiang Y; Li M; Xing X; Pang L; Wang O; Pei Y; Yu LY; Sun Y; Hu Y; Zhou X
    Calcif Tissue Int; 2007 Dec; 81(6):415-20. PubMed ID: 18046499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.
    Saito T; Nishii Y; Yasuda T; Ito N; Suzuki H; Igarashi T; Fukumoto S; Fujita T
    Eur J Endocrinol; 2009 Oct; 161(4):647-51. PubMed ID: 19581284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH).
    Sui T; Yuan L; Liu H; Chen M; Deng J; Wang Y; Li Z; Lai L
    Hum Mol Genet; 2016 Jul; 25(13):2661-2671. PubMed ID: 27126636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling.
    Ishihara Y; Ohata Y; Takeyari S; Kitaoka T; Fujiwara M; Nakano Y; Yamamoto K; Yamada C; Yamamoto K; Michigami T; Mabe H; Yamaguchi T; Matsui K; Tamada I; Namba N; Yamamoto A; Etoh J; Kawaguchi A; Kosugi R; Ozono K; Kubota T
    Bone; 2021 Dec; 153():116135. PubMed ID: 34333162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.
    Ichikawa S; Gray AK; Bikorimana E; Econs MJ
    Calcif Tissue Int; 2013 Aug; 93(2):155-62. PubMed ID: 23700148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel PHEX mutation associated with hypophosphatemic rickets.
    Roetzer KM; Varga F; Zwettler E; Nawrot-Wawrzyniak K; Haller J; Forster E; Klaushofer K
    Nephron Physiol; 2007; 106(1):p8-12. PubMed ID: 17406123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.
    Imel EA; DiMeglio LA; Hui SL; Carpenter TO; Econs MJ
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1846-50. PubMed ID: 20157195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHEX 3'-UTR c.*231A>G near the polyadenylation signal is a relatively common, mild, American mutation that masquerades as sporadic or X-linked recessive hypophosphatemic rickets.
    Mumm S; Huskey M; Cajic A; Wollberg V; Zhang F; Madson KL; Wenkert D; McAlister WH; Gottesman GS; Whyte MP
    J Bone Miner Res; 2015 Jan; 30(1):137-43. PubMed ID: 25042154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.